arrow
Back
S

Shaker A. Mousa

vascular vision pharmaceuticals co.

84H-index
977Paper Count
3.3WCitation Count
Published Papers 277
Publication Date
Retraction notice to "Nanoformulated 3′-diindolylmethane modulates apoptosis, migration, and angiogenesis in breast cancer cells" [Heliyon 10 (2024) e23553]
errHeliyon
IF3.6
err2025-12-10
err0
errOAAI
errSteve Harakeh; Isaac Oluwatobi Akefe; Saber H. Saber; Turki alamri; Rajaa Al-Raddadi; Soad Al-Jaouni; Hanaa Tashkandi; Mohammed Qari; Mohammed Moulay; Alia Aldahlawi; Zakariya Y. Abd Elmageed; Shaker Mousa
errShare
errSave
Editorial Expression of Concern: Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer
err2025-03-01
err0
PREAI
errHariri, Waseem; Sudha, Thangirala; Bharali, Dhruba J.; Cui, Huadong; Mousa, Shaker A.
errShare
errSave
Novel 3′-diindolylmethane nanoformulation induces apoptosis and reduces migration and angiogenesis in liver cancer cells(vol 35, 8, 2024)
err2024-04-01
err0
errOAAI
errHarakeh, Steve; Saber, Saber H.; Alamri, Turki; Al-Raddadi, Rajaa; Al-Jaouni, Soad; Tashkandi, Hanaa; Qari, Mohammed; Qari, Yousef; Akefe, Isaac O.; Elmageed, Zakariya Y. Abd; Haque, Shafiul; Hashem, Anwar M.; Albajri, Eram; Mousa, Shaker
errShare
errSave
Nanoformulated 3′-diindolylmethane modulates apoptosis, migration, and angiogenesis in breast cancer cells
errHELIYON
IF3.6
err2024-01-01
err4
errOAAI
errHarakeh, Steve; Akefe, Isaac Oluwatobi; Saber, Saber H.; Alamri, Turki; Al-Raddadi, Rajaa; Al-Jaouni, Soad; Tashkandi, Hanaa; Qari, Mohammed; Moulay, Mohammed; Aldahlawi, Alia; Elmageed, Zakariya Y. Abd; Mousa, Shaker
errShare
errSave
Novel 3′ -diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
err2023-11-01
err3
errOAAI
errHarakeh, Steve; Saber, Saber H.; Alamri, Turki; Al-Raddadi, Rajaa; Al-Jaouni, Soad; Tashkandi, Hanaa; Qari, Mohammed; Qari, Yousef; Akefe, Isaac O.; Abd Elmageed, Zakariya Y.; Haque, Shafiul; Hashem, Anwar M.; Albajri, Eram; Mousa, Shaker
errShare
errSave
errShare
errSave
Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis
err2023-10-01
err2
errOAAI
errHarakeh, Steve; Saber, Saber Hassan; El-Shitany, Nagla; Ali, Soad S.; Alamri, Turki; Al-Rabia, Mohammed W.; Teklemariam, Addisu Demeke; Zaher, Kawther A.; Sharawi, Zeina W.; Haque, Shafiul; Naseeb, Manal; Albajri, Eram A.; Mousa, Shaker
errShare
errSave
Ellagic acid nanoparticles attenuate oxidative stress and testicular damage in high fat diet/streptozotocin-induce diabetic rats (vol 34, 101720, 2022)
err2023-10-01
err0
errOAAI
errHarakeh, Steve; Qari, Mohammed; Rajeh, Nisreen; Ali, Soad; El-Shitany, Nagla; Hassan, Saber; Abd-Allah, Elham A.; Tashkandi, Hanaa; Malik, Muhammad Faraz Arshad; Aljabri, Feras Khaled; Azhar, Leena; Azhar, Najiah; Al-Jaouni, Soad; Almehmadi, Yousef; Al Amri, Turki; Mousa, Shaker
errShare
errSave
Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. ( vol25, 3031 , 2020 )
err2023-07-25
err0
errOAAI
errNeamatallah, Thikryat; El-Shitany, Nagla; Abbas, Aymn; Eid, Basma G.; Harakeh, Steve; Ali, Soad; Mousa, Shaker
errShare
errSave
A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials
err2023-05-05
err6
PREAI
errKabil, Mohamed Fawzi; Badary, Osama A.; Bier, Frank; Mousa, Shaker A.; El-Sherbiny, Ibrahim M.
errShare
errSave
Pomegranate nanoparticle mitigates cisplatin-induced testicular toxicity and improves cisplatin anti-cancer efficacy in Ehrlich carcinoma model
err2023-05-01
err1
errOAAI
errQari, Mohammed; Harakeh, Steve; Akefe, Isaac O.; Saber, Saber H.; Al-Raddadi, Rajaa; Abd Elmageed, Zakaria Y.; Alamri, Turki; El-Shitany, Nagla; Ali, Soad S.; Almuhayawi, Mohammed S.; Mousa, Shaker
errShare
errSave
Preclinical evaluation of triiodothyronine nanoparticles as a novel therapeutic intervention for resuscitation from cardiac arrest
err2023-05-01
err1
errOAAI
errWeil, Brian R.; Allen, Shannon E.; Barbaccia, Thomas; Wong, Kimberly; Beaver, Abigail M.; Slabinski, Elizabeth A.; Mellott, Jeffrey G.; Dickinson, Peter C. Taylor; Mousa, Shaker A.
errShare
errSave
Preclinical assessment of drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin αvβ3 antagonist
err2023-04-28
err1
errOAAI
errFujioka, Kazutoshi; Fekry, Mostafa I.; Rumsey, Jeanne M.; Steiner, Toni; Thompson, David; Mousa, Shaker A.
errShare
errSave
What is thyroid function in your just-diagnosed cancer patient?
err2023-02-17
err1
errOAAI
errHercbergs, Aleck; Mousa, Shaker A.; Lin, Hung-Yun; Davis, Paul J.
errShare
errSave
Future regenerative medicine developments and their therapeutic applications
err2023-02-01
err18
errOAAI
errAltyar, Ahmed E.; El-Sayed, Amr; Abdeen, Ahmed; Piscopo, Marina; A. Mousa, Shaker; Najda, Agnieszka; Abdel-Daim, Mohamed M.
errShare
errSave